With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.

Haydeh Payami helped uncover the genetic basis of Parkinson’s disease. Now, she hopes to find new ways to treat the disease by studying the gut microbiome.

A new study confirms reports of membrane-bound RNA molecules and points to their role in neutrophil migration.

This year’s Breakthrough Prizes honor advances in CAR T cancer therapies, cystic fibrosis, and Parkinson’s disease.

Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.

The scenarios that run through our sleeping brains may help us explore possible solutions to concerns from our waking lives.

Clinical trials that target human endogenous retroviruses to treat multiple sclerosis, ALS, and other ailments are underway, but many questions remain about how these sequences may disrupt our biology.

To understand how memories are formed and maintained, neuroscientists travel far beyond the cell body in search of answers.

Noncoding RNAs are proving to be critical players in the evolution of brain anatomy and cognitive complexity.

Psychedelics are evolutionarily ancient compounds produced by fungi, plants, and microbes. Humans also synthesize psychedelics. Researchers want to know how and why.